Ilmarinen Mutual Pension Insurance Co Raises Stake in Humana Inc. (NYSE:HUM)

Ilmarinen Mutual Pension Insurance Co lifted its holdings in Humana Inc. (NYSE:HUM - Free Report) by 46.2% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 9,500 shares of the insurance provider's stock after buying an additional 3,000 shares during the period. Ilmarinen Mutual Pension Insurance Co's holdings in Humana were worth $2,410,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Pinnacle Wealth Management Advisory Group LLC boosted its holdings in shares of Humana by 3.6% in the 4th quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider's stock worth $272,000 after buying an additional 37 shares during the last quarter. Atlas Brown Inc. grew its position in shares of Humana by 0.6% during the 4th quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider's stock valued at $1,611,000 after acquiring an additional 38 shares during the period. Mather Group LLC. raised its holdings in shares of Humana by 21.0% in the 4th quarter. Mather Group LLC. now owns 236 shares of the insurance provider's stock worth $60,000 after purchasing an additional 41 shares during the period. Capital Advisors Ltd. LLC increased its position in Humana by 26.1% in the fourth quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider's stock worth $53,000 after buying an additional 43 shares during the last quarter. Finally, Retirement Planning Co of New England Inc. raised its stake in shares of Humana by 4.7% in the fourth quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider's stock valued at $245,000 after buying an additional 43 shares during the period. 92.38% of the stock is currently owned by institutional investors.

Remove Ads

Humana Trading Up 0.9 %

NYSE HUM traded up $2.57 on Friday, hitting $292.82. The company's stock had a trading volume of 622,751 shares, compared to its average volume of 1,744,128. The firm has a market cap of $35.34 billion, a P/E ratio of 29.46, a PEG ratio of 2.05 and a beta of 0.62. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46. The company's 50-day simple moving average is $265.56 and its 200 day simple moving average is $270.77. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Research analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.21%. The ex-dividend date is Friday, March 28th. Humana's dividend payout ratio is currently 35.58%.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the stock. Guggenheim assumed coverage on shares of Humana in a research report on Wednesday. They issued a "buy" rating and a $326.00 price target on the stock. Cantor Fitzgerald reaffirmed a "neutral" rating and set a $290.00 target price on shares of Humana in a report on Wednesday, February 12th. JPMorgan Chase & Co. lowered their price target on shares of Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a report on Tuesday, February 18th. Truist Financial boosted their price objective on shares of Humana from $290.00 to $325.00 and gave the company a "hold" rating in a research note on Friday. Finally, Mizuho increased their target price on shares of Humana from $305.00 to $316.00 and gave the stock an "outperform" rating in a research note on Wednesday. Seventeen investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $286.00.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.